发明授权
- 专利标题： Heterobicyclic carboxamides as inhibitors for kinases
- 专利标题（中）： 异环碳酰胺作为激酶抑制剂
-
申请号： US12281715申请日： 2007-03-09
-
公开(公告)号： US08058276B2公开(公告)日： 2011-11-15
- 发明人: Guido Bold , Andrea Vaupel , Marc Lang
- 申请人： Guido Bold , Andrea Vaupel , Marc Lang
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 John B. Alexander
- 优先权： GB0604937.3 20060310
- 国际申请： PCT/EP2007/052217 WO 20070309
- 国际公布： WO2008/009487 WO 20080124
- 主分类号： C07D413/12
- IPC分类号： C07D413/12 ; C07D417/12 ; A61K31/41
摘要：
The invention relates to novel organic compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.
公开/授权文献
- US20090030009A1 Heterobicyclic Carboxamides as Inhibitors for Kinases 公开/授权日：2009-01-29
信息查询
